Allergan rep has questions ?????


Anonymous

Guest
Allergan rep with questions;

Company car type ?
Roommates at meetings ?
Leveling for experienced reps ?
Health Benefits ?
401k matching amount?
Pension ?
ESPP ?

How many reps in each division -

Dermatology
Plastics
Aesthetics
Urology
Eye Care
Neuroscience

Thank you.
 




Company car type ? Forest fleet cars-- Equinox for Specialty Reps
Roommates at meetings ? Yes roommates
Leveling for experienced reps ?
Health Benefits ? Yes
401k matching amount?
Pension ? No
ESPP ? No

How many reps in each division -

Dermatology --reps have huge territories, not sure what the total number of reps are but theres room for more here.
Plastics ---none
Aesthetics ---none
Urology --- Our new CPU division. I believe its like 300 reps.
Eye Care ---none
Neuroscience CNS division pod set up

Thank you.[/QUOTE]
 


Actavis is known to buy companies, then tell reps to interview for their job and turn around and layoff all reps from company they acquire. The way I see it is all allergan reps will be gone!!
 


Actavis is known to buy companies, then tell reps to interview for their job and turn around and layoff all reps from company they acquire. The way I see it is all allergan reps will be gone!!

I don't understand how they could do this.

Allergan has eye care, where Actavis has none

Allergan has med devices, in which Actavis has none

Allergan as aesthetics in which Acatavis has none

Botox is by far the biggest product of the combined entity especially in Neuro where it's on its way to be a billion dollar drug just for CNS/Rehab/Pain. It's a physician administered injectable procedure with a heavy reimbursement component, its not a 10th in class SSRI or an extended release version of a generic Rx drug (Namenda) There are no samples no real pod system. You just can't lump it in with 4 other me to products who's combined revenue's are not equal to the one in a pod system.

Outside of maybe eye care Allergan's sales forces bring in more money than Actavis's and are much more lean with fewer head count. If any model should be followed it should be Allergan's. Not saying that's what will happen but Allergan is true specialty while these clowns are not.

Uro is the only division in which Allergan reps will definitely have issues. Neuro possibly but Actavist's Neuro products are more physc based and not Nuero/Rehab/Pain.

Botox for all of it's indications in by FAR the best asset of the combined companies. If they were smart they would let the folks on both R&D and Commercial continue to do what they're doing within there respective business units and decide how Actavist and their products and reps fit in, not the other way around. Jerry Lynch should not decide how the Botox sales forces are deployed, the Allergan senior leadership should/need to be deciding that.
 


Simply look at what happened to Warner Chilcott when Actavis bought them. All WC reps interviewed and were all let go. Actavis rather press a restart botton and hire new reps, so they can train reps to sell Actavis way and pay them less. Think about all allergan reps has years of exp, and high pay.
Anyone can do the job, Botox sells itself, hire new people pay them less
 


Simply look at what happened to Warner Chilcott when Actavis bought them. All WC reps interviewed and were all let go. Actavis rather press a restart botton and hire new reps, so they can train reps to sell Actavis way and pay them less. Think about all allergan reps has years of exp, and high pay.
Anyone can do the job, Botox sells itself, hire new people pay them less

Training costs a lot of money as does severance. Not sure it's that easy. Botox does sell itself to a degree I'll admit but again it's a physician administered buy and bill drug meaning issues are always coming up and a new MD just can rx it they need training on how to inject and how to acquire and bill the drug. You don't need hard pushing sales reps but you need account managers to put out fires. Just firing all Allergan related people for this product would cause a major dip in sales and pissed off customers opening the door to competition. Again Botox will be BY FAR the biggest product within this new company and while it does dominate the market it's more complex than RX drugs. Most of Actavis's drugs are crap especially in CNS. They bought their antipsychotic drug from Merck because they knew it was a dog and their two anti-depressants compete in a highly generic market and do less combined than Botox does on its own.

The best asset of this transaction for Actavis is Botox, by far. Why would you fuck with it in any meaningful way?

And again if it's cost savings their after Allergan runs a much leaner ship than Actavis which inherited Forest Labs antiquated pod selling system. Allergan gets more per rep than Actavist Forest does I can guarantee you that.
 


Training costs a lot of money as does severance. Not sure it's that easy. Botox does sell itself to a degree I'll admit but again it's a physician administered buy and bill drug meaning issues are always coming up and a new MD just can rx it they need training on how to inject and how to acquire and bill the drug. You don't need hard pushing sales reps but you need account managers to put out fires. Just firing all Allergan related people for this product would cause a major dip in sales and pissed off customers opening the door to competition. Again Botox will be BY FAR the biggest product within this new company and while it does dominate the market it's more complex than RX drugs. Most of Actavis's drugs are crap especially in CNS. They bought their antipsychotic drug from Merck because they knew it was a dog and their two anti-depressants compete in a highly generic market and do less combined than Botox does on its own.

The best asset of this transaction for Actavis is Botox, by far. Why would you fuck with it in any meaningful way?

And again if it's cost savings their after Allergan runs a much leaner ship than Actavis which inherited Forest Labs antiquated pod selling system. Allergan gets more per rep than Actavist Forest does I can guarantee you that.

Listen, when Actavis bought Forest, we thought there was no way they would change our specialty structure...and Forest management sat in front of us at our team meeting and told us they wouldn't change what was working.

What happened to us is they consolidated our specialty divisions into theirs and combined Urology and Cardiology into the weird CPU division.

They will find a way to shrink you down and "harmonize" with our divisions.
And while Botox is a billion dollar drug, they have plans to make Linzess the next Lexapro. Their strategy to do that was pods and 4,5,6 reps in territories carrying that drug. They will do the same to botox if they get their hands on it.
 


Allergan rep with questions;

Company car type ?
Roommates at meetings ?
Leveling for experienced reps ?
Health Benefits ?
401k matching amount?
Pension ?
ESPP ?

How many reps in each division -

Dermatology
Plastics
Aesthetics
Urology
Eye Care
Neuroscience

Thank you.

Abandon all hope ye who enter here!
You may pray to God that Valiant acquired you.
Albeit Mach frei!
 


Listen, when Actavis bought Forest, we thought there was no way they would change our specialty structure...and Forest management sat in front of us at our team meeting and told us they wouldn't change what was working.

What happened to us is they consolidated our specialty divisions into theirs and combined Urology and Cardiology into the weird CPU division.

They will find a way to shrink you down and "harmonize" with our divisions.
And while Botox is a billion dollar drug, they have plans to make Linzess the next Lexapro. Their strategy to do that was pods and 4,5,6 reps in territories carrying that drug. They will do the same to botox if they get their hands on it.


Your probably right and as someone that worked at Forest I understand how terrible of a culture it is and how sadly outdated it is, but you need to understand you don't sell Botox for any of it's indications the way you sell an Rx. . . "its not doc use Botox first line for your next 10 patients" and sign here, it's an in-office medical procedure closer to a med device sell in some ways. Our speaker programs are training programs to teach MDs how to inject and do the procedure. Doctors have to purchase the product from Allergan and then bill out for the drug and procedure to get reimbursed. It's a money maker for them. It's typically used when RX meds fail. There are no samples as it's a biologic agent that needs to be refrigerated. It's not even close to Linzess or even any of the legacy Actavis specialty products. You can't measure your Botox sales force on how many signatures they got the way you can with Linzess. The same holds true with Allergan's Retina injectable Ozurdex.

Allergan Eyecare on the other hand is run a lot like Forest w/ overlapping pods and signature requirements because the products are mature with samples.

This is a much bigger pill for Actavis to swallow Commercially and from and R&D perspective. Allergan is a far superior company than Actavis in terms of R&D and as a commercial organization so I don't know how they're going to integrate us without destroying the value of their investment, that's why we're running from Valeant. And again outside of eyecare and maybe Derm none of our products are sampled. They are purchased and reimbursed and sold to true specialist ones who do interventional procedures not just Rx.
 


Company car type ? Forest fleet cars-- Equinox for Specialty Reps
Roommates at meetings ? Yes roommates
Leveling for experienced reps ?
Health Benefits ? Yes
401k matching amount?
Pension ? No
ESPP ? No

How many reps in each division -

Dermatology --reps have huge territories, not sure what the total number of reps are but theres room for more here.
Plastics ---none
Aesthetics ---none
Urology --- Our new CPU division. I believe its like 300 reps.
Eye Care ---none
Neuroscience CNS division pod set up

Thank you.
[/QUOTE]

THANK YOU!
 


Your probably right and as someone that worked at Forest I understand how terrible of a culture it is and how sadly outdated it is, but you need to understand you don't sell Botox for any of it's indications the way you sell an Rx. . . "its not doc use Botox first line for your next 10 patients" and sign here, it's an in-office medical procedure closer to a med device sell in some ways. Our speaker programs are training programs to teach MDs how to inject and do the procedure. Doctors have to purchase the product from Allergan and then bill out for the drug and procedure to get reimbursed. It's a money maker for them. It's typically used when RX meds fail. There are no samples as it's a biologic agent that needs to be refrigerated. It's not even close to Linzess or even any of the legacy Actavis specialty products. You can't measure your Botox sales force on how many signatures they got the way you can with Linzess. The same holds true with Allergan's Retina injectable Ozurdex.

Allergan Eyecare on the other hand is run a lot like Forest w/ overlapping pods and signature requirements because the products are mature with samples.

This is a much bigger pill for Actavis to swallow Commercially and from and R&D perspective. Allergan is a far superior company than Actavis in terms of R&D and as a commercial organization so I don't know how they're going to integrate us without destroying the value of their investment, that's why we're running from Valeant. And again outside of eyecare and maybe Derm none of our products are sampled. They are purchased and reimbursed and sold to true specialist ones who do interventional procedures not just Rx.

Urologists that are "hospital-owned" inject Botox in their OR (hospital / ASC). This product can't be dumped in a POD bag. It's not about signatures. It is an actual procedure.

The Plastic (breast) reps are also in the OR. Probably sold off if Actavis buys Allergan.
 


Urologists that are "hospital-owned" inject Botox in their OR (hospital / ASC). This product can't be dumped in a POD bag. It's not about signatures. It is an actual procedure.

The Plastic (breast) reps are also in the OR. Probably sold off if Actavis buys Allergan.



That's my point. Even a lot Neuro injections are done in out patient Hospital facilities as well as large private Neuro/PMR practices you cant just go to every Neuro and PCP and ask for Botox Scripts same with Urology.

Ozurdex is only done by Retinal surgeons in their practices can't go to high potential PCPs with that product as well. ..

Not being Arrogant but Allergan is a true specialty/Biotech/Device . . . while we can do some big pharma things, ie DTC and what not the sales structures are much much different. We have larger territories, fewer targets, more hands on selling ie explaining the technical aspects of teh procedure and the reimbursement, not just a sales message
 


Actavis is known to buy companies, then tell reps to interview for their job and turn around and layoff all reps from company they acquire. The way I see it is all allergan reps will be gone!!

Wrong answer; they only fired all of the Warner Chilcott Reps. If you know anything about Warner Chilcott, you would completely understand why. Here is a hint, Actavis had a requirement of 2 years of experience to be hired; 80%+ of the WC reps did not meet that requirement. We wont even talk about the used car type selling culture at WC.
 




Actavis bought Forest. Forest runs Actavis and has kept very few of its solid practices. The same will happen to Allergen

Yea I don't think you get it though, while you can be cheap and give us roommates and all of that Forest crap the selling model for medical procedures is different than Rx.

The pod, reach frequency, used car salesman tough outdated can still be used with Rx drugs but it can not be used for devices or Botox which is an office based procedure. Gi drugs and SSRi's can be used by anyone not just specialists this is not the case with Botox therapeutic.

I don't think you guys understand this. Now I now how stupid the people at Forest labs are but it will be strange to sell our products the way you do your Rx Drugs. Doctors will not understand what you are saying to them. You don't get "signatures" for breast implants or Botox, or Juviderm.
 


Yea I don't think you get it though, while you can be cheap and give us roommates and all of that Forest crap the selling model for medical procedures is different than Rx.

The pod, reach frequency, used car salesman tough outdated can still be used with Rx drugs but it can not be used for devices or Botox which is an office based procedure. Gi drugs and SSRi's can be used by anyone not just specialists this is not the case with Botox therapeutic.

I don't think you guys understand this. Now I now how stupid the people at Forest labs are but it will be strange to sell our products the way you do your Rx Drugs. Doctors will not understand what you are saying to them. You don't get "signatures" for breast implants or Botox, or Juviderm.

No. I do understand it. You obviously understand it. But based on Forest history I don't hold out hope of THEM understanding it. They are of the opinion that the methods that made Celexa and Lexapro blockbusters will work in every situation every time. Based on their string of not block busters since then it SHOULD put an end to that theory but hasn't. They will apply this same method to any new acquisition because if it worked for those 2 drugs and will work for anything.
 


No. I do understand it. You obviously understand it. But based on Forest history I don't hold out hope of THEM understanding it. They are of the opinion that the methods that made Celexa and Lexapro blockbusters will work in every situation every time. Based on their string of not block busters since then it SHOULD put an end to that theory but hasn't. They will apply this same method to any new acquisition because if it worked for those 2 drugs and will work for anything.

Truth. There's a lot of Actavis/Watson reps that understand what you are saying and we agree with you too. But this guy is right, Forest DOESN'T get it and that is the problem.
 


No. I do understand it. You obviously understand it. But based on Forest history I don't hold out hope of THEM understanding it. They are of the opinion that the methods that made Celexa and Lexapro blockbusters will work in every situation every time. Based on their string of not block busters since then it SHOULD put an end to that theory but hasn't. They will apply this same method to any new acquisition because if it worked for those 2 drugs and will work for anything.

It'll be strange then to see how this goes. . . "Exuse me Mr. Neurologist will use Botox first line for all of your Chronic Migraine, Cervical Dystonia, and Upper Limb Spactisity patients?"

"I don't inject or do the procedure for the 20th time, I refer to the big Neurology group down the road"?

"Ok will you sign for me"

"you're going to give me Botox samples, even though I don't inject"

"No I just need a signature, we don't sample Botox"

Seriously you can't approach this the same way not only will it be annoying it'll be weird.
 


Truth. There's a lot of Actavis/Watson reps that understand what you are saying and we agree with you too. But this guy is right, Forest DOESN'T get it and that is the problem.

Agree with above poster. Take all of your experience, territory and business knowlwedge along with one shred of logic and just throw it out the window. You bring up solid insight, however there is a huge disconnect between the leadership team and reality in specialty divisions.
One never knows how it will be impacted or implemented...IF the deal actually goes through.
 



Write your reply...